article Open access
Letter by Dong et al Regarding Article, “CYP2C19 Polymorphisms and Antiplatelet Effects of Clopidogrel in Acute Ischemic Stroke in China”
Yi Donga, Xin Chenga, Qiang Donga
- aDepartment of Neurology, Huashan Hospital, Fudan University, Shanghai, China
Looking for the full paper…
Papers open inside SciRah from the original publisher or repository; SciRah never hosts them.
Abstract
No abstract is available from our sources. Use “Read paper” to view it.
TL;DRIt is proposed that patients with none of these polymorphisms had better outcomes than patients with CYP2C19 loss-of-function alleles, as demonstrated by the National Institute of Health Stroke Scale and the modified Rankin scale scores after treatment. (Semantic Scholar)